{
    "nct_id": "NCT05812274",
    "official_title": "A Phase IV Study of Apricity C.A.R.E. Program for Cancer Adverse Events Rapid Evaluation to Improve Treatment Outcomes of Ethnic/Racial Minority Non-small Cell Lung Cancer (NSCLC) Patients Receiving Immunotherapy",
    "inclusion_criteria": "* Ageâ‰¥ 18 years\n* Confirmed NSCLC diagnosis\n* Prescribed treatment with immune-checkpoint inhibitor, including in combination with chemotherapy\n* Ability to understand and the willingness to sign a written informed consent document\n* Self-identification as a member of an ethnic minority or underserved population.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* An individual with presence of any medical, psychological, or social condition that, in the opinion of the investigator would preclude participation in this study.\n* Patients enrolled in other interventional clinical trials at the time of screening will be excluded.",
    "miscellaneous_criteria": ""
}